Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02477943 · ClinicalTrials.gov registry record
Objective Brain Function Assessment of mTBI/Concussion in College Athletes
A clinical trial, sponsored by BrainScope Company.
- Completed
- Registry status
- 520
- Enrollment target
NCT02477943: Completed study, sponsored by BrainScope Company.
NCT02477943 is a clinical trial that has completed, run by BrainScope Company. The registered enrollment target is 520 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02477943 has completed, sponsored by BrainScope Company.
- COMPLETED
- Registry status
- 520 participants
- Enrollment target
Study Summary
This study (Part 1) is designed to build a database including EEG, neurocognitive performance, clinical symptoms, history and other relevant data, which will be used to derive a multimodal EEG based algorithm for the identification of concussion and tracking of recovery. In addition, neuroimaging will be conducted at time of injury and following Return to Play (RTP).
Primary Outcome
Create a database of brain electrical activity (EEG) and clinical information collected from athletes who sustain a concussion during organized sports.
Interventions
- DEVICE BrainScope Ahead 200iD
- DEVICE Advanced MRI Neuroimaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 520 participants |
| Start Date | 2015-08-08 |
| Est. Completion | 2017-07-31 |
What the finished NCT02477943 record still lists
NCT02477943 is an observational study that tracks outcomes without assigning an intervention. The registered 520 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which BrainScope Ahead 200iD is the first listed.
NCT02477943 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02477943 about?
NCT02477943 is a clinical study titled "Objective Brain Function Assessment of mTBI/Concussion in College Athletes". This study (Part 1) is designed to build a database including EEG, neurocognitive performance, clinical symptoms, history and other relevant data, which will be used to derive a multimodal EEG based algorithm for the identification of concussion and tracking of recovery. In addition, neuroimaging wi...
What is the current status of trial NCT02477943?
This trial is currently completed. The enrollment target is 520 participants. The study started on 2015-08-08. Estimated completion is 2017-07-31.
What interventions are being tested in trial NCT02477943?
The interventions under investigation include: BrainScope Ahead 200iD (DEVICE), Advanced MRI Neuroimaging (DEVICE).
Who is sponsoring clinical trial NCT02477943?
This trial is sponsored by BrainScope Company, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
- NCT04656496 · 520 participants · NA
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
- NCT05445778 · 520 participants · Phase 3
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- NCT05498428 · 520 participants · Phase 2
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI